Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction The Ludwigshafen Risk and Cardiovascular Health Study

被引:39
|
作者
Kleber, Marcus E. [2 ]
Renner, Wilfried [3 ]
Grammer, Tanja B. [1 ]
Linsel-Nitschke, Patrick [4 ]
Boehm, Bernhard O. [5 ]
Winkelmann, Bernhard R. [6 ]
Bugert, Peter [7 ]
Hoffmann, Michael M. [8 ]
Maerz, Winfried [1 ,9 ]
机构
[1] Synlab Ctr Lab Diagnost Heidelberg, POB 10 47 80, D-69037 Heidelberg, Germany
[2] LURIC Study Nonprofit LLC, Freiburg, Germany
[3] Med Univ Graz, Inst Clin, Med & Chem Lab Diagnost, Graz, Austria
[4] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany
[5] Univ Hosp, Dept Med, Div Endocrinol & Diabet, Ulm, Germany
[6] Frankfurt Sachsenhausen, Cardiol Grp, Frankfurt, Germany
[7] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, D-6800 Mannheim, Germany
[8] Univ Med Ctr Freiburg, Dept Med, Div Clin Chem, Freiburg, Germany
[9] Heidelberg Univ, Med Fac Mannheim, Inst Publ Hlth Social & Prevent Med, D-6800 Mannheim, Germany
关键词
Atherosclerosis; Cardiovascular disease; Myocardial infarction; Sortilin; rs599839; GENOME-WIDE ASSOCIATION; DENSITY; LOCI; CHOLESTEROL;
D O I
10.1016/j.atherosclerosis.2009.09.068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The rs599839 polymorphism A/G in the vicinity of the sortilin 1 gene has been reported to be associated with low density lipoprotein cholesterol (LDL-C) and coronary artery disease (CAD). The objective of this study was to further characterize the protective effect of the minor allele by analyzing the association with a variety of quantitative traits. Methods: Association of rs599839 with plasma levels of different parameters of LDL and triglyceride (TRIG) metabolism as well as the risk of CAD was tested in the LURIC study cohort. Results: Compared to AA homozygotes, the levels of LDL-C, low density lipoprotein triglycerides (LDLTRIG) and apolipoprotein B were decreased in carriers of at least one G-allele. The G-allele was also associated with an increasing radius of the LDL particles. Regarding TRIG metabolism we observed a significant decrease in the level of triglycerides for homozygous carriers of the G-allele as well as decreased levels of free fatty acids (FFA), free glycerol and free cholesterol. With each G-allele the prevalence of CAD (multivariate OR 0.806; 95% CI: 0.692-0.940, P = 0.006) decreased significantly whereas we observed only a marginal decrease for MI which did not reach significance. For GG homozygotes, the OR for CAD was 0.588 (95% CI: 0.394-0.877; P = 0.009) and the OR for previous myocardial infarction (MI) was 0.693 (95% CI: 0.490-0.980; P = 0.038). These associations were independent of cardiovascular risk factors. Conclusion: In the LURIC Study the G-allele of rs599839 is associated with LDL and TRIG metabolism and the risk of coronary artery disease and myocardial infarction. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:492 / 497
页数:6
相关论文
共 34 条
  • [1] The C-514T polymorphism in the promoter of the gene for hepatic lipase. association with coronary heart disease, myocardial infarction and all cause mortality in the Ludwigshafen risk and cardiovascular health study
    Ahl, D
    Hoffmann, MM
    Seelhorst, U
    Winkelmann, BR
    Boehm, BO
    Maerz, WG
    CIRCULATION, 2005, 112 (17) : U294 - U294
  • [2] C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
    Nauck, M
    Winkelmann, BR
    Hoffmann, MM
    Böhm, BO
    Wieland, H
    März, W
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (11): : 1249 - +
  • [3] SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction in the Ludwigshafen risk and cardiovascular health study
    Grammer, TB
    Renner, W
    Hoffmann, MM
    Winkelmann, BR
    Boehm, BO
    März, W
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 4 - 4
  • [4] Alanine to serine polymorphism at position 986 of the calcium sensing receptor associated with coronary heart disease and myocardial infarction.: (The Ludwigshafen Risk and Cardiovascular Health Atudy)
    März, W
    Hoffmann, M
    Renner, W
    Boehm, B
    Winkelman, B
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 87 - 87
  • [5] Association between single nucleotide polymorphism rs11057401 of CCDC92 gene and the risk of coronary heart disease (CHD)
    Xiao, Lingyan
    Shi, Dongyang
    Zhang, Hui
    Zhang, Yanchun
    Liu, Yongfu
    Lu, Hu
    Zheng, Yishan
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [6] Association between single nucleotide polymorphism rs11057401 of CCDC92 gene and the risk of coronary heart disease (CHD)
    Lingyan Xiao
    Dongyang Shi
    Hui Zhang
    Yanchun Zhang
    Yongfu Liu
    Hu Lu
    Yishan Zheng
    Lipids in Health and Disease, 17
  • [7] Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)
    Kleber, Marcus E.
    Grammer, Tanja B.
    Renner, Wilfried
    Maerz, Winfried
    BMC MEDICAL GENETICS, 2010, 11
  • [8] SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
    Grammer, Tanja B.
    Renner, Wilfried
    Hoffmann, Michael M.
    Kleber, Markus
    Winkelhofer-Roob, Brigitte M.
    Boehm, Bernhard O.
    Maerz, Winfried
    FREE RADICAL RESEARCH, 2009, 43 (07) : 677 - 684
  • [9] The Syntaxin-1A gene single nucleotide polymorphism rs4717806 associates with the risk of ischemic heart disease
    Guerini, Franca R.
    Ripamonti, Enrico
    Costa, Andrea S.
    Zanzottera, Milena
    Agliardi, Cristina
    Bolognesi, Elisabetta
    Clerici, Mario
    Racca, Vittorio
    MEDICINE, 2019, 98 (24)
  • [10] The-50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease:: The Ludwigshafen risk and cardiovascular health study
    Hoffmann, Michael M.
    Bugert, Peter
    Seelhorst, Ursula
    Wellnitz, Britta
    Winkelmann, Bernhard R.
    Boehms, Bernhard O.
    Maerz, Winfried
    CLINICAL CHEMISTRY, 2007, 53 (03) : 539 - 540